Cargando…

Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis

AIM: Insulin-like growth factor 1 (IGF-1), which is primarily produced in hepatocytes and is associated with liver functional reserve, plays a crucial role in the pathological condition of cirrhosis. This study aimed to investigate the usefulness of serum IGF-1 levels for predicting the long-term pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeki, Chisato, Kanai, Tomoya, Ueda, Kaoru, Nakano, Masanori, Oikawa, Tsunekazu, Torisu, Yuichi, Saruta, Masayuki, Tsubota, Akihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405075/ https://www.ncbi.nlm.nih.gov/pubmed/37554499 http://dx.doi.org/10.3389/fmed.2023.1233928

Ejemplares similares

Prognostic significance of sarcopenia and severe vitamin D deficiency in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Osteosarcopenia predicts poor survival in patients with cirrhosis: a retrospective study
por: Saeki, Chisato, et al.
Publicado: (2023)

Low Serum Branched-chain Amino Acid and Insulin-Like Growth Factor-1 Levels Are Associated with Sarcopenia and Slow Gait Speed in Patients with Liver Cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2020)

Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2021)

The Geriatric Nutritional Risk Index predicts sarcopenia in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Low geriatric nutritional risk index predicts poor prognosis in patients with cirrhosis: a retrospective study
por: Kamioka, Hiroshi, et al.
Publicado: (2023)

Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis
por: Saeki, Chisato, et al.
Publicado: (2022)

Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2020)

Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2020)

Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Clinical Usefulness of FRAX Score for Predicting Sarcopenia in Patients with Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Safety and efficacy of pentazocine–midazolam combination for pain and anxiety relief in radiofrequency ablation therapy for hepatocellular carcinoma
por: Nakano, Masanori, et al.
Publicado: (2022)

Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis
por: Saeki, Chisato, et al.
Publicado: (2020)

Effects of denosumab treatment in chronic liver disease patients with osteoporosis
por: Saeki, Chisato, et al.
Publicado: (2020)

Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2019)

Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2019)

Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2018)

Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis
por: Torisu, Yuichi, et al.
Publicado: (2017)

Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis: A cohort study
por: Ueda, Kaoru, et al.
Publicado: (2022)

Potential significance of uncovered self‐expandable metal stents for distal malignant biliary obstruction: A propensity score‐adjusted competing risk regression analysis
por: Torisu, Yuichi, et al.
Publicado: (2022)

Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis
por: Saeki, Chisato, et al.
Publicado: (2022)

Plasma pentosidine as a useful biomarker of sarcopenia, low gait speed, and mortality in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras
por: Kamioka, Hiroshi, et al.
Publicado: (2023)

Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms
por: Torisu, Yuichi, et al.
Publicado: (2019)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Pregnancy Is Not Associated with an Increased Risk of Decompensation, Transplant, or Death in Compensated Cirrhosis
por: Mullin, Monica, et al.
Publicado: (2022)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history
por: Romero‐Cristóbal, Mario, et al.
Publicado: (2022)

Hemobilia Derived from Cystic Artery Pseudoaneurysm
por: Tanaka, Takayuki, et al.
Publicado: (2019)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease
por: Saeki, Chisato, et al.
Publicado: (2021)

Six-minute walk test predicts future decompensation in patients with compensated liver cirrhosis
por: Henrique, Diane Michela Nery, et al.
Publicado: (2022)

Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study
por: Tapper, Elliot B., et al.
Publicado: (2019)

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy
por: Li, Mingyu, et al.
Publicado: (2023)

Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
por: Hassan, Elham Ahmed, et al.
Publicado: (2019)

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
por: Park, Jihye, et al.
Publicado: (2017)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_966a2c2gidd5b2ue5v2uvgt36r